Caplin Point gains as its arm gets USFDA’s approval for Calcium Gluconate Injection
Mumbai, May 5 (Udaipur Kiran): Caplin Point Laboratories is currently trading at Rs. 1738.60, up by 2.70 points or 0.16% from its previous closing of Rs. 1735.90 on the BSE. The scrip opened at Rs. 1735.05 and has touched a high and low of Rs. 1774.25 and Rs. 1728.05 respectively. So far 5958 shares were … Read more
